(Q45861991)

17 December 2017

title

Catalytic activity of antibodies against factor VIII in patients with hemophilia A. (English)

1 reference

17 December 2017

Sébastien Lacroix-Desmazes

main subject

hemophilia

0 references

Coagulation factor VIII

0 references

0 references

1 reference

1

1 reference

17 December 2017

author name string

Moreau A

2

1 reference

17 December 2017

Sooryanarayana

3

1 reference

17 December 2017

Bonnemain C

4

1 reference

17 December 2017

Stieltjes N

5

1 reference

17 December 2017

Pashov A

6

1 reference

17 December 2017

Sultan Y

7

1 reference

17 December 2017

Hoebeke J

8

1 reference

17 December 2017

Kazatchkine MD

9

1 reference

17 December 2017

Kaveri SV

10

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

17 December 2017

published in

Nature Medicine

1 reference

17 December 2017

volume

5

1 reference

17 December 2017

issue

9

1 reference

17 December 2017

page(s)

1044-1047

1 reference

17 December 2017

Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs

cites work

1 reference

7 January 2021

Slowed release of thrombin-cleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for factor VIII inhibition

1 reference

7 January 2021

Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid

1 reference

7 January 2021

Thrombin-activated and factor Xa-activated human factor VIII: Differences in cofactor activity and decay rate

1 reference

7 January 2021

Guidelines for therapy and optimal dosages of coagulation factors for treatment of bleeding and surgery in haemophilia

1 reference

7 January 2021

A polyclonal antibody preparation with Michaelian catalytic properties.

1 reference

7 January 2021

Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule

1 reference

7 January 2021

Activation of porcine factor VIII:C by thrombin and factor Xa.

1 reference

7 January 2021

Inactivation of factor VIII by factor IXa

1 reference

7 January 2021

Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity

1 reference

7 January 2021

Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor

1 reference

7 January 2021

Distribution of factor VIII mRNA and antigen in human liver and other tissues

1 reference

7 January 2021

DNA hydrolyzing autoantibodies

1 reference

7 January 2021

DNA-specific antiidiotypic antibodies in the sera of patients with autoimmune diseases

1 reference

7 January 2021

Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use.

1 reference

7 January 2021

Identifiers

DOI

10.1038/12483

1 reference

17 December 2017

Dimensions Publication ID

1026540437

0 references

1 reference

17 December 2017